MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy
2025 · Cancer Gene Therapy · 37 citations
https://doi.org/10.1038/s41417-025-00886-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
78
Citations
4
h-index
2
i10-index
Nada Mohamady Farouk Abdalsalam is an academic researcher from Shenzhen Institutes of Advanced Technology. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction & Ferroptosis and cancer prognosis. The author has an h-index of 4, co-authored 5 publications.
https://doi.org/10.1038/s41417-025-00886-9
https://doi.org/10.3390/cells14020108
Click to start Chat